Company: SMNR
Filing Date: 2025-05-12
Form Type: 425
Source: 0001213900-25-041656
Chunk: 1

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-05-12
Form: 425
Chunk 1
---
                 |
| Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share |     | DNQWF             |     | OTCQB                 |

Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On May 9, 2025, Denali Capital Acquisition Corp.
issued a press release announcing that it deposited $874.78 into the Trust Account in order to extend the period of time it has to consummate
a business combination by one month, from the current deadline of May 11, 2025 to June 11, 2025, a copy of which is attached hereto as
Exhibit 99.1.

Item 9.01. Financial Statement and Exhibits.

(d) Exhibits.

| Exhibit No. 
 99.1        |     | Description                                                                  
 Press Release, dated May 9, 2025                                             |
|:------------|:----|:-----------------------------------------------------------------------------|
| 104         |     | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

<div align='center'>1

SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date: May 9, 2025 | DENALI CAPITAL ACQUISITION CORP. 
 By:                              | /s/ Lei Huang           |
|:------------------|:---------------------------------|:------------------------|
|                   | Name:                            | Lei Huang               |
|                   | Title:                           | Chief Executive Officer |

<div align='center'>2</div>